Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
62.56
+0.47 (0.76%)
At close: Jul 27, 2026, 4:00 PM EDT
62.54
-0.02 (-0.03%)
After-hours: Jul 27, 2026, 7:59 PM EDT
BMY Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 127,752 | 109,822 | 114,760 | 103,698 | 150,951 | 135,674 | |
Market Cap Growth | 28.16% | -4.30% | 10.67% | -31.30% | 11.26% | -2.53% |
Enterprise Value | 163,329 | 144,293 | 153,603 | 131,245 | 181,075 | 163,321 |
Last Close Price | 62.56 | 53.94 | 56.56 | 51.31 | 71.95 | 62.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.52 | 15.59 | - | 13.29 | 24.39 | 19.98 |
Forward PE | 10.21 | 8.73 | 7.96 | 6.85 | 9.26 | 8.00 |
PEG Ratio | - | 0.10 | 10.92 | 16.44 | 3.55 | 2.31 |
PS Ratio | 2.64 | 2.28 | 2.38 | 2.30 | 3.27 | 2.92 |
PB Ratio | 6.37 | 5.94 | 7.03 | 3.52 | 4.86 | 3.77 |
P/FCF Ratio | 10.73 | 8.55 | 8.23 | 8.20 | 12.63 | 8.91 |
P/OCF Ratio | 9.60 | 7.76 | 7.55 | 7.48 | 11.55 | 8.37 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.37 | 2.99 | 3.18 | 2.92 | 3.92 | 3.52 |
EV/EBITDA Ratio | 12.05 | 10.30 | 72.66 | 7.70 | 9.75 | 9.04 |
EV/EBIT Ratio | 16.40 | 14.43 | - | 18.02 | 21.85 | 22.14 |
EV/FCF Ratio | 13.72 | 11.23 | 11.02 | 10.37 | 15.16 | 10.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.21 | 2.44 | 3.03 | 1.35 | 1.26 | 1.24 |
Debt / EBITDA Ratio | 3.28 | 3.22 | 23.49 | 2.33 | 2.12 | 2.47 |
Debt / FCF Ratio | 3.73 | 3.51 | 3.56 | 3.14 | 3.29 | 2.93 |
Net Debt / Equity Ratio | 1.69 | 1.86 | 2.38 | 0.93 | 0.97 | 0.77 |
Net Debt / EBITDA Ratio | 2.51 | 2.46 | 18.35 | 1.61 | 1.62 | 1.53 |
Net Debt / FCF Ratio | 2.85 | 2.68 | 2.78 | 2.17 | 2.52 | 1.81 |
Asset Turnover | 0.55 | 0.53 | 0.51 | 0.47 | 0.45 | 0.41 |
Inventory Turnover | 5.30 | 5.35 | 5.35 | 4.28 | 4.57 | 4.77 |
Quick Ratio | 1.04 | 0.94 | 0.91 | 1.04 | 0.87 | 1.20 |
Current Ratio | 1.42 | 1.26 | 1.25 | 1.43 | 1.25 | 1.52 |
Return on Equity (ROE) | 37.67% | 40.44% | -38.95% | 26.53% | 18.91% | 18.99% |
Return on Assets (ROA) | 8.55% | 8.28% | -8.50% | 7.23% | 6.62% | 5.61% |
Return on Invested Capital (ROIC) | 14.11% | 13.99% | -14.23% | 11.74% | 10.93% | 9.38% |
Return on Capital Employed (ROCE) | 14.88% | 14.77% | -10.56% | 9.85% | 10.21% | 7.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.69% | 6.41% | - | 7.52% | 4.10% | 5.00% |
FCF Yield | 9.32% | 11.70% | 12.15% | 12.20% | 7.92% | 11.23% |
Dividend Yield | 4.03% | 4.60% | 4.24% | 4.47% | 3.02% | 3.17% |
Payout Ratio | 70.28% | 71.51% | -54.44% | 59.00% | 73.03% | 62.67% |
Buyback Yield / Dilution | -0.47% | -0.59% | 2.45% | 3.17% | 4.41% | 0.58% |
Total Shareholder Return | 3.56% | 4.01% | 6.70% | 7.64% | 7.43% | 3.75% |